Stephanie Reuter Lange
0000-0003-3888-7287
University of South Australia
90 papers found
Refreshing results…
The Influence of a Therapeutic Drug Monitoring Service on Vancomycin‐Associated Nephrotoxicity
Opportunities for clinical decision support targeting medication safety in remote primary care management of chronic kidney disease: A qualitative study in Northern Australia
Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development
Determining Plasma Tacrolimus Concentrations Using High-Performance LC-MS/MS in Renal Transplant Recipients
Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study
Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug Monitoring
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
Analytical and Non-Analytical Variation May Lead to Inappropriate Antimicrobial Dosing in Neonates: An In Silico Study
Effect of Therapeutic Plasma Exchange on Itraconazole Pharmacokinetics: A Case Study
Blood, dose recommendation reports and phone calls ‐ Experiences of a Therapeutic Drug Monitoring Advisory Service for vancomycin
Protocol: 2021/06-QA25111. Improving oral prostate cancer medications through lipid-hybrid re-formulation
Protocol: PQ-110-001. A randomised, double-masked vehicle-controlled, multiple dose, dose escalation study to evaluate the safety and tolerability of EXN407 in subjects with centre involved diabetic macular oedema secondary to diabetes mellitus
Protocol: ADX-324-101. A phase I, single ascending dose study in healthy volunteers and an expansion cohort in patients with hereditary angioedemia to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-324 (Interim Analysis#1)
Protocol: ADX-324-01. A phase I, single ascending dose study in healthy volunteers and an expansion cohort in patients with hereditary angioedemia to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-324 (Interim Analysis #2)
Protocol: AQL-001. A plasma pharmacokinetic study with ALT-100 monoclonal antibody administered to Sprague Dawley rats by the intravenous and subcutaneous routes
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand
Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
Review and evaluation of vancomycin dosing guidelines for obese individuals
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults
Missing publications? Search for publications with a matching author name.